Duloxetine

Product NDC
70771-1344
11-digit product format
707711344
Labeler code
70771
Product ID
70771-1344_f1dcb903-231c-46b8-b388-ba6a3272bd9d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Duloxetine
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Labeler
Zydus Lifesciences Limited
Application
ANDA090728
Marketing category
ANDA
Marketing start
2014-05-27
Marketing end
0000-00-00
Substance
DULOXETINE HYDROCHLORIDE
Active strength
20 mg/1
Pharmacologic classes
Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
70771-1344-0707711344001000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70771-1344-0) 2017-04-060000-00-00NoNoCurrent
70771-1344-37077113440330 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70771-1344-3) 2014-05-270000-00-00NoNoCurrent
70771-1344-67077113440660 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70771-1344-6) 2014-05-270000-00-00NoNoCurrent
70771-1344-97077113440990 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70771-1344-9) 2014-05-270000-00-00NoNoCurrent